Kindred Biosciences Inc.

NASDAQ: KIN · Real-Time Price · USD
9.25
0.01 (0.11%)
At close: Apr 24, 2025, 3:47 PM

Kindred Biosciences Revenue Breakdown

Period Ending Dec 31, 2020
Asset Sale Revenue 38.7M
Asset Sale Revenue Growth n/a
Manufacturing Revenue 1.55M
Manufacturing Revenue Growth n/a
Partner Licensing Revenue 500K
Partner Licensing Revenue Growth n/a
Product Revenue Revenue 878K
Product Revenue Revenue Growth n/a
Royalty Revenue 535K
Royalty Revenue Growth n/a

Operating Expense Breakdown

Period Ending Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 5.87M 4.68M 3.3M 4.7M 5.11M 8.87M 9.58M 9.38M 9.06M 9.9M 9.22M 6.61M 5.77M 4.9M 4.82M 3.27M 3.06M 2.84M 2.4M 2.02M 1.86M 2.02M 1.88M 2.1M 1.92M 1.95M
Selling, General, and Administrative Revenue Growth +25.30% +41.81% -29.69% -7.97% -42.47% -7.36% +2.09% +3.50% -8.44% +7.40% +39.51% +14.52% +17.71% +1.70% +47.45% +6.97% +7.49% +18.41% +18.74% +8.42% -7.67% +7.39% -10.21% +9.06% -1.64% n/a
Research and Development Revenue 5.57M 6.29M 7.63M 7.39M 7.4M 8.87M 7.13M 7.29M 6.73M 7.15M 7.76M 7.48M 5.82M 5.35M 5.14M 4.88M 3.87M 3.78M 3.51M 3.75M 3.16M 3.44M 4.58M 5.03M 4.99M 4.81M
Research and Development Revenue Growth -11.36% -17.59% +3.28% -0.15% -16.57% +24.29% -2.14% +8.26% -5.84% -7.79% +3.73% +28.47% +8.87% +3.97% +5.43% +26.15% +2.28% +7.72% -6.53% +18.76% -8.03% -24.94% -9.02% +0.84% +3.78% n/a